Page 5 - Sanger Sequencing News Today

AUSTIN, Texas, Aug. 18, 2022 /PRNewswire/ -- Data Bridge Market research has recently released expansive research titled "Global Human Microbiome Market" guarantees you will remain better informed

/PRNewswire/ -- Data Bridge Market research has recently released expansive research titled "Global Human Microbiome Market" guarantees you will remain better...

The Business Research Company’s Next Generation Sequencing Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

In a recent study posted to the medRxiv* pre-print server, KU Leuven researchers investigated whether there was an association between the intensity of the co-circulation of adenovirus (AdV) 40/41 and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with the number of hepatitis cases of unknown origin emerging in Belgium.

Search for improved disease-resistant breeds, increased adoption of advanced genetic technologies to prevent genetic diseases and business loss, and other factors is leading to growth of the

/PRNewswire/ -- Verified Market Research recently published a report, "Animal Genetics Market" By Type (Animal Genetics Products, Genetic Materials, Embryo),...

Companion diagnostics (CDx) are developed in parallel to the drug using the drug-diagnostic co-development model...

The Telomere-to-Telomere Consortium identified the last sequences, revealing a 100 percent complete human genome for the first time.

A new study has found that the Novaplex SARS-CoV-2 Variant I, II, and IV real-time PCR assays (from Seegene Technology) can reliably detect SARS-CoV-2 in patient samples and identify known variants of interest and concern.

Researchers develop two SARS-CoV-2 Mutation Discrimination assays that have been designed to detect 501 and 484 mutations on the spike protein.